About the Authors
- Myriam Rai
-
Affiliation Laboratoire de Neurologie Expérimentale, Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium
- Elisabetta Soragni
-
Affiliation Department of Molecular Biology, The Scripps Research Institute, La Jolla, California, United States of America
- Kai Jenssen
-
Current address: Merz Pharmaceutical GmbH, Frankfurt am Main, Germany
Affiliation Department of Molecular Biology, The Scripps Research Institute, La Jolla, California, United States of America
- Ryan Burnett
-
Affiliation Department of Molecular Biology, The Scripps Research Institute, La Jolla, California, United States of America
- David Herman
-
Affiliation Department of Molecular Biology, The Scripps Research Institute, La Jolla, California, United States of America
- Giovanni Coppola
-
Affiliation Program in Neurogenetics, Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America
- Daniel H. Geschwind
-
Affiliation Program in Neurogenetics, Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America
- Joel M. Gottesfeld
-
Affiliation Department of Molecular Biology, The Scripps Research Institute, La Jolla, California, United States of America
- Massimo Pandolfo
-
* E-mail: massimo.pandolfo@ulb.ac.be
Affiliation Laboratoire de Neurologie Expérimentale, Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium
Competing Interests
MP and JMG are consultants for Repligen, Inc., that has licensed the described HDAC inhibitors for the Scripps Research Institute. The other authors have no competing interests.
Author Contributions
Conceived and designed the experiments: MP MR DG JG. Performed the experiments: MR GC ES KJ RB DH. Analyzed the data: MP MR GC DG JG. Contributed reagents/materials/analysis tools: ES KJ RB DH. Wrote the paper: MP MR DG JG.